Hikma Pharmaceutical | Resultat Før Skatt



Pre Tax Profit Endring Dato
Almirall EUR 15.17M 72K 2024-06
argenx SE USD 88.02M 103.02M 2024-09
AstraZeneca USD 1.67B 162M 2024-12
Autolus Therapeutics Ltd -82070000 23.85M 2024-09
Bayer EUR -481000000 805M 2024-12
Fresenius EUR 401M 14M 2024-12
Galapagos EUR 19.03M 68.17M 2024-12
Genmab DKK 3.6B 1.88B 2024-12
GlaxoSmithKline GBP 563M 2.08B 2024-12
GRIFOLS EUR 66.98M 38.41M 2024-06
Hikma Pharmaceutical USD 144M 144M 2024-06
Lonza CHF 427M 167M 2024-06
Merck EUR 809M 425.38M 2024-12
Orion EUR 91.7M 109.7M 2024-12
Recordati EUR 150.03M 19.43M 2024-09
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.18B 1.33B 2024-12
UCB EUR 123M 464.07M 2024-06



Hikma Pharmaceutical Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.